CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 100 enrolled
Drug / intervention
vascular access device placementprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00607880
NCT00607880Phase 2Completed
CompareCT.gov

A Prospective Randomized Study of the Vortex® Implantable Access Port Versus the BardPort™ Implantable Port in Cancer Patients Receiving Adjuvant Intravenous Chemotherapy

Mayo Clinic·interventional·Posted Feb 6, 2008·Updated May 9, 2014

In Brief

A Phase 2 clinical trial evaluating vascular access device placement for Unspecified Adult Solid Tumor, Protocol Specific and Vascular Access Device Complications. Completed, enrolled 100 participants across 1 site.

Detailed Summary

RATIONALE: Giving chemotherapy drugs through an implanted port reduces the need for multiple needle sticks. It is not yet known whether one type of port is more effective than another in reducing infections and other side effects associated with long-term port use. PURPOSE: This randomized clinical trial is comparing two types of ports in patients with cancer receiving intravenous chemotherapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUnspecified Adult Solid Tumor, Protocol Specific, Vascular Access Device Complications
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

Phase 2CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 6, 2008
Enrollment StartJun 1, 2004
Primary CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 18.4 years ago

Interventions

vascular access device placementprocedure